Overview
Wai Yuen Tong
?
CHING HO TANG
See more contacts
Activities Related to Real Estate
,
Pharmaceutical and Medicine Manufacturing
,
Drugs and Druggists' Sundries Merchant Wholesalers
,
Grocery and Related Product Merchant Wholesalers
,
Real estate managers
See All Industries , Investment holding companies, except banks , Pharmaceutical preparations , Pharmaceuticals Health foods
See Fewer Industries
See All Industries , Investment holding companies, except banks , Pharmaceutical preparations , Pharmaceuticals Health foods
See Fewer Industries
?
$100.82 million
Actual
8.33%
$2,095
MAR
?
?
Hong Kong:00897
Contacts
Get in Touch with 7 Principals*
-
CHING HO TANGAuthorised Representative
-
Contact 2?
-
Contact 3?
-
Contact 4?
Dynamic search and list-building capabilities
Real-time trigger alerts
Comprehensive company profiles
Valuable research and technology reports
Financial Statements
Dun & Bradstreet collects private company financials for more than 23 million companies worldwide. Find out more.
Financial data as of March 31, 2025 (12 month period) in USD
Annual Revenue 2024
$100.82 million
USD
Actual
1 USD = 7.7748 HKD
All financial statement data is in millions except per share data | Source: Morningstar
| Cash Flow (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Net Operating Cash | $25 | $22 | $22 |
| Net Investing Cash | -$11 | $2 | $1 |
| Net Financing Cash | -$60 | -$20 | -$26 |
| Net Change in Cash | -$47 | $4 | -$4 |
| Cash at Beginning of Period | $68 | $66 | $65 |
| Cash at End of Period | $20 | $68 | $66 |
| Capital Expenditure | -$4 | -$4 | -$3 |
| Assets (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Assets | |||
| Cash and Cash Equivalents | $20 | $68 | $66 |
| Accounts Receivable | $10 | $9 | $8 |
| Inventories | $40 | $211 | $240 |
| Other Current Assets | $37 | $61 | $57 |
| Asset Summary | |||
| Total Current Assets | $107 | $348 | $372 |
| Tangible Fixed Assets | $86 | $124 | $123 |
| Intangible Assets | $ | $ | $ |
| Total Assets | $2,095 | $7,014 | $7,598 |
| Liabilities (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Current Liabilities | |||
| Accounts Payable | $4 | $10 | $11 |
| Short-Term Debt | $24 | $79 | $82 |
| Other Current Liabilities | $21 | $124 | $149 |
| Liability Summary | |||
| Total Current Liabilities | $49 | $213 | $242 |
| Long-Term Debt | $36 | $133 | $134 |
| Other Long-Term Liabilities | $ | $ | $ |
| Total Liabilities | $91 | $428 | $468 |
| Stakeholder's Equity (mil) | 2024 | 2023 | 2022 |
|---|---|---|---|
| Equity | |||
| Common Stock | $2 | $2 | $2 |
| Retained Earnings | -$11 | -$15 | -$11 |
| Equity Summary | |||
| Total Equity | $178 | $302 | $324 |
| Shares Outstanding | 1,171,102,888 | 1,204,642,888 | 1,231,642,888 |